BAPTISTHEALTH
MIAMINEUROSCIENCE
INSTITUTE
TheImpactofYourGenerosity
Donationsaremakingatransformativeimpactinthelivesofpatientsand staffatBaptistHealthMiamiNeuroscienceInstitute.Yourgenerosityhas beeninstrumentalinpoweringextraordinarycare,makingitpossibleto:
Purchaseequipmentandtechnologytoenhancepatientcare
ObtainedBrainPath®,aninnovativetoolusedtohelpsupport precisenavigationthroughnaturalpathwaysinthebrainwith minimaldisruptiontosurroundingbraintissueduringneurosurgical craniotomyhemorrhageprocedures ByusingBrainPath®,clinicians candeliverthelatestminimallyinvasivetreatmentsandadvanced technologies.
FundedVisionTree®,adigitalhealthcareplatformthathelps patientsandproviderstrackhealthdata,shareinformationsecurely andmanagecaremoreeffectively.UtilizedbyMichaelW. McDermott,M.D.,chiefmedicalexecutiveofMiamiNeuroscience InstituteandtheIrma&KalmanBassEndowedChairinClinical Neuroscience,VisionTreeisfundedbyphilanthropyandhas impactedDr McDermott’sobservationstudyfocusingon meningiomas Theplatformofferstoolstoanalyzecollecteddata, allowspatientstoinputtheirsymptomsandsupportscliniciansin creatingpersonalizedcareplans.Thankstothisinnovativeplatform, Dr.McDermottcantrackhispatients’progressandidentifythe optimaltimetooperate.
FundedDiscoverymode(FC+)forQuicktome™,apowerfultool tailoredforneurologicalresearch,helpingcliniciansanalyzebrainrelateddataquicklyandprecisely.Itenhancespatientcareby identifyingcriticaltrendsandprovidingreal-timeinsights Evidence-basedtreatmentdirectlycontributestoimproved outcomesandoperationalefficiency
ConstructedanADA-compliantrampforpatientstohaveaccessto Zap-X®technology,acutting-edgeroboticsystemthatdelivers highlytargetedradiationforthetreatmentofbraintumorsand neurologicalconditions.Thisnon-invasive,precision-driven approachminimizesdamagetohealthytissue,offeringasaferand moreeffectivealternativetotraditionalsurgery.Thanksto philanthropy,thisADA-compliantrampensuresallpatients, regardlessofmobilitychallenges,haveequalaccesstothe lifesavingbenefitsofZap-Xtechnology,promotinginclusivityand providingcriticaltreatmentopportunities.
Miami NeuroscienceInstitute
Educateourdedicatedstaffandtrainthenextgenerationofclinicians
SupportedthesecondcohortofNeuroscienceResearchScholarsat MiamiNeuroscienceInstitute,fundingtheworkofthreescholars. Thisimmersiveprogramfostersthenextgenerationofhealthcare leadersbyprovidingmentorship,exposuretocutting-edge treatmentsandadeeperunderstandingofneurologicalscience Philanthropyhelpscultivateyoungmindswhowillshapethefuture ofmedicalinnovationandpatientcare.
GavestafftheopportunitytoattendtheNeuroscienceNursing AnnualConference,providingthemwithinformationaboutthe latestadvancementsinneurosciencecareandofferingworkshops, expert-ledsessionsandnetworkingopportunities.Throughtheir participation,staffgainedcriticalknowledge,enhancedtheir clinicalskillsandreturnedwithvaluableinformationtosharewith theirteams,ensuringtheyremainattheforefrontofpatientcare
Conductcutting-edgeresearch
ContinuedtheExablateBlood-BrainBarrier(BBB)Disruptionstudy, whichaimstoexploreagroundbreakingtreatmentapproachfor Alzheimer'sdiseasebyusingfocusedultrasoundtotemporarily opentheblood-brainbarrier,allowingmedicationstobetterreach thebrain Thisinnovativetechniquecouldsignificantlyimprovedrug delivery,offeringnewhopeforpatientswithAlzheimer'swho currentlyhavelimitedtreatmentoptions Bysupportingthis research,donorshelppavethewayfortransformativetherapies thatcouldchangethelivesofmillionsaffectedbythischallenging condition.
SupportedtheHEMERA-1Study,whichexplorestheuseofadrug namedCarboxyHEMoglobintoimproveoxygendeliveryand promoterevascularizationinpatientswithacuteischemicstroke. Thisapproachaimstoenhancerecoveryandminimizebrain damageduringthecriticalearlystagesofastroke LedbyItalo Linfante,MD,directorofinterventionalneuroradiology,thisstudy hasthepotentialtotransformcurrentstroketreatmentsand improvelong-termoutcomesforpatients.Throughphilanthropic support,Dr.Linfantewasabletopublishhisresearchandshowcase evidenceofthedrug’ssafety.
ANewErainNeurologicalCare
ThefutureofMiamiNeuroscienceInstituteissettoreachnewheights,thankstothe transformativesupportofKennethC.Griffin,whosehistoric$50milliongiftismakinga lastingimpactontheInstitute’sgrowthandvision.Thisremarkabledonationishelpingto fundanewstate-of-the-artbuildingwhichwillsignificantlyenhancepatientcareand expandtheInstitute’scapacitytoservethecommunity Thenewfacilitywillallowfor advancedtreatmentsandfosteranenvironmentofhealing,helpingtomeettherising demandforspecializedneurologicalcare.
Inaddition,theInstituteestablishedtheDistinguishedEndowedChairinNeurology throughananonymousgiftthatwillfurthertheInstitute'scommitmentto groundbreakingresearch.DiegoTorres-Russotto,M.D.,whowasrecentlyinstalledasthe inauguralholderofthischair,willleadinnovativestudiesintoconditionslikeParkinson’s diseaseanddystonia.Thiscombinationofexpandedfacilitiesandworld-classresearch initiativeswillpositionMiamiNeuroscienceInstituteasaleaderinneuroscience, advancingtreatmentoptionsforpatientswhileenhancingthecareandservices availabletothecommunity
PowerExtraordinary:TheCampaignforBaptistHealthisahistoricfundraisinginitiativeby Baptist Health Foundation in support of Baptist Health, the largest not-for-profit healthcare organization in South Florida. The campaign aims to raise a record $600 million in philanthropic donations as an investment in the communities Baptist Health serves. The initiativewillsupporttheorganization’svisionofprovidingworld-class,compassionatehealth resources by pursuing a reimagined approach to patient care, a new era in research and clinical trials, a hub for the best minds in medicine and a globally recognized center for innovation. Funds raised through the campaign will help enhance patient care throughout BaptistHealth’sserviceareas,whichincludeMiami-Dade,Monroe,BrowardandPalmBeach counties; and will help drive breakthroughs in research and innovation that will make the organizationarenownedleaderinhealthcare,nationallyandinternationally
